OncoBone Therapeutics nominates Dr. Theresa Guise and Dr. Paul Kostenuik as advisors in our newly established Advisory Board.
Dr. Jussi Halleen, CEO of OncoBone Therapeutics says: “We are proud to nominate Dr. Guise and Dr. Kostenuik as the first advisors in our Advisory Board. Their expertise will have a strong impact in achieving our goals for developing novel therapies for bone metastasizing cancers.”
Read more in: https://www.oncobonetherapeutics.com/about-us/advisors/